To study the effect of myrtle fruit in patients of abnormal vaginal discharge

Efficacy of Habbulaas in Sayalan al-Rahim: A Randomized Controlled Trial - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029958

Enrollment

Registered

2020-12-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N768- Other specified inflammation of vagina and vulva

Interventions

Intervention1: Sharbat habbulaas (Myrtus communis): 5ml of sharbat habbulaas will be given TID orally for the duration of 2 weeks Control Intervention1: Combination of Fluconazole, Azithromycin and Or

Eligibility

Inclusion criteria

Inclusion criteria: Married women above 18 years with regular menstrual cycle Women presenting with abnormal vaginal discharge and/or associated with any of these symptoms such as pruritus vulvae, low backache, lower abdominal pain and dysuria

Exclusion criteria

Exclusion criteria: Pregnant, lactating and unmarried women Genital prolapse and unhealthy cervix Suspected organic pelvic pathology Patients with systemic and metabolic diseases Patients with syphilis, gonorrhoea, HIV and malignancy H/o OCP use and IUCD insertion within 3 months before enrolment H/o antibiotic use within one month

Design outcomes

Primary

Measure	Time frame
Improvement in abnormal vaginal discharge and/or any associated symptoms assessed by VAS Improvement in the quality of life (SF-12 score)Timepoint: 14th day, 30th day	—

Secondary

Measure	Time frame
Vaginal pH Whiff test KOH mount Saline mountTimepoint: 14th day	—

Countries

India

Contacts

Public ContactDr Mariyam Roqaiya

Department of Niswan wa Qabala

dr.mroqaiya@gmail.com9632560839

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026